The Polypill (Acetyl Salicylic Acid, Atorvastatin, and Ramipril) Paradigm Shift in Secondary Prevention: Global Expert Delphi Consensus.
- DOI
- 10.5334/gh.1466
- Published
- 2025
- Container
- Global heart
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5334/gh.1466,
title = {The Polypill (Acetyl Salicylic Acid, Atorvastatin, and Ramipril) Paradigm Shift in Secondary Prevention: Global Expert Delphi Consensus.},
author = {Piñeiro D and González-Juanatey JR and Abreu A and Alvarez EG and Ponte-Negretti C and Weisser B and Parkhomenko A and Araújo F and Sosa-Liprandi A},
year = {2025},
journal = {Global heart},
doi = {10.5334/gh.1466},
url = {https://doi.org/10.5334/gh.1466}
}RIS
TY - JOUR TI - The Polypill (Acetyl Salicylic Acid, Atorvastatin, and Ramipril) Paradigm Shift in Secondary Prevention: Global Expert Delphi Consensus. AU - Piñeiro D AU - González-Juanatey JR AU - Abreu A AU - Alvarez EG AU - Ponte-Negretti C AU - Weisser B AU - Parkhomenko A AU - Araújo F AU - Sosa-Liprandi A PY - 2025 JO - Global heart DO - 10.5334/gh.1466 UR - https://doi.org/10.5334/gh.1466 ER -
APA
D, P., JR, G., A, A., EG, A., C, P., B, W., A, P., F, A., & A, S. (2025). The Polypill (Acetyl Salicylic Acid, Atorvastatin, and Ramipril) Paradigm Shift in Secondary Prevention: Global Expert Delphi Consensus.. Global heart. https://doi.org/10.5334/gh.1466
Source records
- pubmed · retrieved 2026-09-26T23:15:41.332Z